CSI Market
Sign In | Register

Biomerica Inc (BMRA) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BMRA Annual Cash Flow →
The quarterly cash flow data below helps track how Biomerica Inc's liquidity profile has evolved over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(May 31 2026)
12 Months 		(Feb 28 2026) (Nov 30 2025) (Aug 31 2025) (May 31 2025)
Operating Activities
Income-3.78
Depreciation & amortization0.08
Amortization of Other Assets0.02
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.01
Inventories Decrease /-Increase0.06
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.48
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Increase Decrease In Deferred Rent Liability-
Operating Lease Right Of Use Asset Amortization Expense0.25
Increase Decrease In Contract With Customer Liability-0.03
Increase Decrease In Operating Lease Liability-0.27
Income taxes0.00
Losses/ -gains on Investments net0.34
Accounts Receivable-0.10
Increase (Decrease) in Accounts Payable and Accrued Liabilities0.50
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.04
Other Working Capital-0.02
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.97
Discontinued operations0.00
Net Cash flow from Operating Activities-3.42
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.50
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock1.83
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Stock Options And Warrants Exercised-
Proceeds From Common Stock Subscribed-
Proceeds From Equity Financing Officer-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations2.40
Payments Of Deferred Offering Costs-
Proceeds From Deferred Offering Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities2.33
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-3.42
Total Cash Flow-1.09
4 historic quarters locked

Sign in to unlock the full Biomerica Inc cash flow history.

Sign In Create Free Account

About Biomerica Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260228)
  • Filed with the SEC: April 13, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-016388

Figures are derived from filed reports and may be restated. Historical data is subject to revision.